​

LifeMD (LFMD) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LFMD Stock Forecast

LifeMD (LFMD) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $10.33, with a high of $12.00 and a low of $7.00. This represents a 80.59% increase from the last price of $5.72.

$4 $5 $6 $7 $8 $9 $10 $11 $12 High: $12 Avg: $10.33 Low: $7 Last Closed Price: $5.72

LFMD Stock Rating

LifeMD stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 5 Strong Sell Sell Hold Buy Strong Buy

LFMD Forecast vs Benchmarks

TypeNameUpside
StockLifeMD80.59%
SectorHealthcare Stocks 25.20%

Price Target Trends

1M3M12M
# Anlaysts125
Avg Price Target$7.00$9.50$11.40
Last Closing Price$5.72$5.72$5.72
Upside/Downside22.38%66.08%99.30%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25171--9
Dec, 24171--9
Nov, 2416---7
Oct, 2416---7
Sep, 2416---7
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 08, 2025Scott SchoenhausKeyBanc$7.00$5.5426.35%22.38%
Dec 10, 2024Brooks O'NeilLake Street$12.00$5.97101.01%109.79%
Oct 14, 2024Kyle BauserBTIG$12.00$4.64158.62%109.79%
Jun 04, 2024Steve DechertKeyBanc$12.00$7.5359.36%109.79%
Apr 23, 2024David LarsenBTIG$14.00$10.0040.00%144.76%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Jan 08, 2025KeyBancOverweightOverweighthold
Dec 10, 2024Lake StreetBuyinitialise
Oct 14, 2024BTIGBuyBuyhold
Jul 11, 2024KeyBancOverweightOverweighthold
Jun 04, 2024KeyBancOverweightinitialise
May 21, 2024B. RileyBuyBuyhold
May 09, 2024Cantor FitzgeraldOverweightOverweighthold
Apr 23, 2024BTIGBuyBuyhold
Jul 21, 2023Cantor FitzgeraldOverweightinitialise
May 16, 2022BTIGBuyBuyhold

Financial Forecast

EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 $1 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-4.24$-2.27$-1.45$-0.61----
Avg Forecast$-3.09$-1.70$-1.34$-0.71$-0.55$-0.04$0.13-
High Forecast$-3.17$-1.74$-1.40$-0.72$-0.57$-0.05$0.05-
Low Forecast$-3.03$-1.67$-1.31$-0.69$-0.52$-0.03$0.21-
Surprise %37.22%33.53%8.21%-14.08%----

Revenue Forecast

$0 $90M $180M $270M $360M $450M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$37.29M$92.88M$119.03M$152.55M----
Avg Forecast$37.30M$92.92M$124.49M$148.99M$205.64M$257.17M$301.48M$383.70M
High Forecast$36.77M$91.62M$122.39M$148.94M$205.34M$251.99M$293.89M$374.05M
Low Forecast$38.03M$94.76M$128.46M$149.04M$205.94M$263.15M$315.12M$401.07M
Surprise %-0.00%-0.05%-4.39%2.39%----

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-60.52M$-61.32M$-45.02M$-20.60M----
Avg Forecast$-104.77M$-57.64M$-45.43M$-23.70M$-18.58M$-1.36M$4.41M-
High Forecast$-107.46M$-59.12M$-47.31M$-24.48M$-19.40M$-1.63M$1.58M-
Low Forecast$-102.86M$-56.59M$-44.44M$-23.47M$-17.76M$-1.08M$7.23M-
Surprise %-42.23%6.39%-0.91%-13.11%----

LFMD Forecast FAQ

Is LifeMD stock a buy?

LifeMD stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that LifeMD is a favorable investment for most analysts.

What is LifeMD's price target?

LifeMD's price target, set by 5 Wall Street analysts, averages $10.33 over the next 12 months. The price target range spans from $7 at the low end to $12 at the high end, suggesting a potential 80.59% change from the previous close price of $5.72.

How does LifeMD stock forecast compare to the average forecast of its sector, industry, and investment themes?

LifeMD stock forecast shows a 80.59% upside, outperforming the average forecast for the healthcare stocks sector (25.20%).

What is the breakdown of analyst ratings for LifeMD over the past three months?

  • January 2025: 11.11% Strong Buy, 77.78% Buy, 11.11% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 11.11% Strong Buy, 77.78% Buy, 11.11% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 14.29% Strong Buy, 85.71% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is LifeMD’s EPS forecast?

LifeMD's average annual EPS forecast for its fiscal year ending in December is -0.55 for 2024, a -9.84% decrease from the reported $-0.61 in 2023. The prediction for 2025 is $-0.04, $0.13 for 2026, and $0 for 2027.

What is LifeMD’s revenue forecast?

LifeMD's average annual revenue forecast for its fiscal year ending in December is $205.64M for 2024, a 34.81% increase from the reported $152.55M in 2023. The forecast for 2025 is $257.17M, $301.48M for 2026, and $383.7M for 2027.

What is LifeMD’s net income forecast?

For its fiscal year ending in December, LifeMD's average annual net income forecast is $-18.58M for 2024, reflecting a -9.79% decrease from the reported $-20.596M in 2023. The projection for 2025 is $-1.356M, $4.41M for 2026, and $0 for 2027.